Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease

被引:210
|
作者
Nativio, Raffaella [1 ]
Donahue, Greg [1 ]
Berson, Amit [2 ]
Lan, Yemin [1 ]
Amlie-Wolf, Alexandre [3 ]
Tuzer, Ferit [4 ]
Toledo, Jon B. [3 ]
Gosai, Sager J. [2 ]
Gregory, Brian D. [2 ]
Torres, Claudio [4 ]
Trojanowski, John Q. [3 ]
Wang, Li-San [3 ]
Johnson, F. Brad [3 ]
Bonini, Nancy M. [2 ]
Berger, Shelley L. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Epigenet Program, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA
[4] Drexel Univ, Coll Med, Dept Pathol, Philadelphia, PA 19104 USA
关键词
HISTONE H4 ACETYLATION; DNA-DAMAGE; GENE-EXPRESSION; LYSINE; 16; DEVELOPMENTAL REGULATION; SENESCENCE; ACTIVATION; PROTEIN; BRAIN; TRANSCRIPTION;
D O I
10.1038/s41593-018-0101-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Aging is the strongest risk factor for Alzheimer's disease (AD), although the underlying mechanisms remain unclear. The chromatin state, in particular through the mark H4K16ac, has been implicated in aging and thus may play a pivotal role in age-associated neurodegeneration. Here we compare the genome-wide enrichment of H4K16ac in the lateral temporal lobe of AD individuals against both younger and elderly cognitively normal controls. We found that while normal aging leads to H4K16ac enrichment, AD entails dramatic losses of H4K16ac in the proximity of genes linked to aging and AD. Our analysis highlights the presence of three classes of AD-related changes with distinctive functional roles. Furthermore, we discovered an association between the genomic locations of significant H4K16ac changes with genetic variants identified in prior AD genome-wide association studies and with expression quantitative trait loci. Our results establish the basis for an epigenetic link between aging and AD.
引用
收藏
页码:497 / +
页数:11
相关论文
共 50 条
  • [31] Cerebrospinal Fluid Epinephrine in Alzheimer's Disease and Normal Aging
    Elaine R Peskind
    Rachael Elrod
    Dorcas J Dobie
    Marcella Pascualy
    Eric Petrie
    Carl Jensen
    Kayla Brodkin
    Sharon Murray
    Richard C Veith
    Murray A Raskind
    Neuropsychopharmacology, 1998, 19 : 465 - 471
  • [32] Alzheimer's disease and normal aging: Neurophysiological and immunological aspects
    Ivnev, BB
    NEUROPHYSIOLOGY, 1999, 31 (01) : 23 - 25
  • [33] The cognitive transition from normal aging to Alzheimer's disease
    Bäckman, L
    BRAIN AND COGNITION, 1999, 39 (01) : 5 - 6
  • [34] Cortical variability and asymmetry in normal aging and Alzheimer's disease
    Thompson, PM
    Moussai, J
    Zohoori, S
    Goldkorn, A
    Khan, AA
    Mega, MS
    Small, GW
    Cummings, JL
    Toga, AW
    CEREBRAL CORTEX, 1998, 8 (06) : 492 - 509
  • [35] Neuronal changes in normal human aging and Alzheimer's disease
    Uylings, HBM
    de Brabander, JM
    BRAIN AND COGNITION, 2002, 49 (03) : 268 - 276
  • [36] Processing of semantic relations in normal aging and Alzheimer's disease
    Peraita, H.
    Diaz, C.
    Anllo-Vento, L.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2008, 23 (01) : 33 - 46
  • [37] Cerebrospinal fluid epinephrine in Alzheimer's disease and normal aging
    Peskind, ER
    Elrod, R
    Dobie, DJ
    Pascualy, M
    Petrie, E
    Jensen, C
    Brodkin, K
    Murray, S
    Veith, RC
    Raskind, MA
    NEUROPSYCHOPHARMACOLOGY, 1998, 19 (06) : 465 - 471
  • [38] Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging
    delaTorre, JC
    GERONTOLOGY, 1997, 43 (1-2) : 26 - 43
  • [39] Advances at the intersection of normal brain aging and Alzheimer's disease
    Wilmott, Lynda A.
    Neuner, Sarah M.
    Burger, Corina
    Kaczorowski, Catherine
    BEHAVIOURAL BRAIN RESEARCH, 2017, 322 : 187 - 190
  • [40] Specificity of inhibitory deficits in normal aging and Alzheimer's disease
    Collette, Fabienne
    Schmidt, Christina
    Scherrer, Christine
    Adam, Stephane
    Salmon, Eric
    NEUROBIOLOGY OF AGING, 2009, 30 (06) : 875 - 889